Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-4.15	73.11	76.28
Graham Fair Price	4.67	5.69	5.43
PEG	-74.19	1.06	-4.11
Price/Book	12.44	6.45	5.73
Price/Cash Flow	106.35	-156.22	75.71
Prices/Earnings	-16.11	26.54	31.64
Price/Sales	-3.67	11.86	12.31
Price/FCF	106.35	-156.22	75.71
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.80	0.35	0.34
Operating Margin	5.63	0.14	0.13
ROA	21.27	0.03	0.03
ROE	0.05	0.06	34.04
ROIC	0.04	0.04	14.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.54	< 0.005	21226.95
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.08	0.11	42.53
EPS QOQ	-0.08	0.25	225.00
FCF QOQ	0.26	-1.49	482.46
Revenue QOQ	< 0.005	0.05	621.79
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	71.61	73.59	2.77
Inventory Turnover	0.00	285611000.00	100.00
Debt/Capitalization	0.19	0.31	59.80
Quick Ratio	1.91	2.32	21.45
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.38	4.87	-9.60
Cash	1.78	1.52	-14.99
Capex	-0.07	-0.07	3.58
Free Cash Flow	0.41	-0.20	-50.74
Revenue	2.51	2.64	5.53
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.07	2.53	22.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.91	4.09	114.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating